−69.1
4D Molecular Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−86.7
FY23:
−75.8
FY24:
−135
FY25:
−109
Change from FY21 to FY25
millions USD
FY21:
−173
FY22:
−17.1
FY23:
116
FY24:
−302
FY25:
−93.0
Change from FY21 to FY25
millions USD
FY21:
118
FY22:
3.09
FY23:
157
FY24:
337
FY25:
113
millions USD
FY21:
−124
FY22:
−101
FY23:
197
FY24:
−99.8
FY25:
−89.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−78.2
FY22:
−98.2
FY23:
−78.6
FY24:
−138
FY25:
−110
All amounts in millions USD